Search results
Results From The WOW.Com Content Network
For patients younger than 2–3 years of age, treatment with radiation is not used, once they are in a more vulnerable phase and, thus, more prone to risks in development. [1] Examinations such as CSF analysis and spinal MRIs are used to investigate the effectiveness of treatment in preventing metastasis .
Distinct from adult T-cell leukemia (in which T-cell lymphotropic virus Type I causes malignant maturation of T-cells), T-ALL is a precursor for lymphoid neoplasm. [6] Its clinical presentation most commonly includes infiltration of the central nervous system (CNS, i.e. brain and spinal cord), and is often associated with a mediastinal mass ...
A nervous system neoplasm is a tumor that arises within the nervous system, either the central nervous system (CNS) or the peripheral nervous system (PNS). [ 1 ] [ 2 ] . Nervous system neoplasms include various types of brain and spinal cord tumors, such as gliomas , and meningiomas (of the CNS), and schwannomas (of the PNS) and can be either ...
A central nervous system tumor (CNS tumor) is an abnormal growth of cells from the tissues of the brain or spinal cord. [1] CNS tumor is a generic term encompassing over 120 distinct tumor types. [2]
This is an accepted version of this page This is the latest accepted revision, reviewed on 3 February 2025. Neoplasm in the brain Medical condition Brain tumor Other names Intracranial neoplasm, brain tumour, brain cancer Brain metastasis in the right cerebral hemisphere from lung cancer, shown on magnetic resonance imaging Specialty Neurosurgery, neuro-oncology Symptoms Vary depending on the ...
Microglioma and Primary brain lymphoma [1] Brain magnetic resonance imaging showing primary central nervous system B-cell non-Hodgkin lymphoma of the sella turcica and hypothalamus, continuing to the tectum (intensely white areas in the middle). Specialty: Hematology and Neuro-oncology
A larger number of cases that contain a longer clinical follow-up are needed to optimize the management of patients with this rare disease. [ 5 ] Even though there is a general consensus on the morphology and the immunohistochemical characteristics that is required for the diagnosis, the histological grading criteria have yet to be fully ...
The concept of grading of the tumors of the central nervous system, agreeing for such the regulation of the "progressiveness" of these neoplasias (from benign and localized tumors to malignant and infiltrating tumors), dates back to 1926 and was introduced by P. Bailey and H. Cushing, [1] in the elaboration of what turned out the first systematic classification of gliomas.